
    
      Two doses of Sirolimus will be evaluated accorded to the CYP 3A5 genotype. Patients carrying
      at least CYP 3A5 *1 allele will receive 4 mg per day whereas the others (CYP 3A5 *3/*3) will
      receive 2 mg.
    
  